Animal Health Service, Bavaria, Senator-Gerauer-Str. 23, 85586 Poing, Germany.
Animal Health Service, Bavaria, Senator-Gerauer-Str. 23, 85586 Poing, Germany.
Vaccine. 2024 Mar 19;42(8):1993-2003. doi: 10.1016/j.vaccine.2024.02.048. Epub 2024 Feb 21.
Q fever in humans is caused by Coxiella (C.) burnetii. In 2008 and 2012, cases of Q fever in humans were linked to an infected flock of approximately 650 ewes. Since 2013 gimmers (G'13, G'14, G'15 etc.) were primary vaccinated (two doses) with an inactivated C.burnetii vaccine without any revaccination. In 2013, 30 ewes were primary vaccinated (A'13). Shedding was annually monitored by qPCR-testing of vaginal and nasal swabs collected at lambing. Animals were tested for Phase I- (PhI) and PhII-antibodies (Ab) and for PhII-specific-interferon-γ (IFN-γ) before and after vaccination. The effect of a revaccination was determined in 2018 and 2023. Groups of randomly selected gimmers primary vaccinated in 2015, 2016 and 2017 and a mixed group of older animals (A'13, G'13 and G'14) were revaccinated once in 2018. The trial was repeated in 2023 on groups primary vaccinated in 2019-2023. Major shedding after the outbreak in 2012 ceased in 2014. Thereafter C.burnetii was only sporadically detected at low-level in 2018, 2021 and 2023. Sheep naturally exposed to C.burnetii during the outbreak in 2012 (A'13, G'13) mounted a strong and complete (PhI, PhII, IFN-γ) recall immune response after vaccination. A serological PhI/PhII pattern dominated after vaccination. In contrast, since 2014 a weaker immune response (PhII-titre, IFN-γ) and a dominance of the PhI/PhII pattern was observed in vaccinated gimmers. The number of serologically non-responding gimmers to vaccination increased to 25.0 % in G'16/G'17 and 40.4 % in G'19/G'20. But revaccination even three (G'15 in 2018) and four (G'19 in 2023) years after primary vaccination resulted in a strong and complete immune response. No difference of the immune response nor to more recently primary vaccinated animals (G'23 in 2023) nor to those animals that were present during the outbreak (A'13/G'13/G'14 in 2018) was observed.
人类 Q 热是由贝氏柯克斯体(Coxiella (C.) burnetii)引起的。2008 年和 2012 年,人类 Q 热病例与一群约 650 只感染的绵羊有关。自 2013 年以来,小母羊(G'13、G'14、G'15 等)已接受过两次灭活贝氏柯克斯体疫苗的初级接种(无加强接种)。2013 年,30 只小母羊接受了初级接种(A'13)。通过在产羔时收集阴道和鼻腔拭子的 qPCR 检测,每年监测脱落情况。在接种前后,对动物进行了 I 期(PhI)和 II 期(PhII)抗体(Ab)和 PhII 特异性干扰素-γ(IFN-γ)检测。2018 年和 2023 年确定了加强接种的效果。2015 年、2016 年和 2017 年随机选择的小母羊初级接种组和一组年龄较大的动物(A'13、G'13 和 G'14)于 2018 年接受了一次加强接种。该试验于 2023 年再次在 2019 年至 2023 年期间进行初级接种的组中进行。2012 年疫情爆发后,主要脱落于 2014 年停止。此后,2018 年、2021 年和 2023 年仅偶尔在低水平检测到贝氏柯克斯体。在 2012 年疫情期间自然接触贝氏柯克斯体的绵羊(A'13、G'13)在接种后产生了强烈而完全的(PhI、PhII、IFN-γ)回忆免疫反应。接种后,血清学 PhI/PhII 模式占主导地位。相比之下,自 2014 年以来,接种的小母羊的免疫反应较弱(PhII 滴度、IFN-γ),并且 PhI/PhII 模式占主导地位。对疫苗接种无反应的小母羊的数量增加到 25.0%在 G'16/G'17 和 40.4%在 G'19/G'20。但在初级接种后三年(G'15 年在 2018 年)和四年(G'19 年在 2023 年)进行加强接种,仍会导致强烈而完全的免疫反应。未观察到免疫反应的差异,也未观察到最近进行过初级接种的动物(G'23 年在 2023 年)或在疫情期间存在的动物(A'13/G'13/G'14 年在 2018 年)的差异。